MGO One Seven’s Rigel Pharmaceuticals RIGL Stock Holding History

MGO One Seven’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-100	Closed	-$2K	–	1370
2018 Q4	$2K	Buy	+100	New	+$2.82K	﹤0.01%	1592

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

MGO One Seven's RIGL Position: Q1 2019 in Review

MGO One Seven sold out of Rigel Pharmaceuticals (RIGL) in Q1 2019, closing a stake of 100 shares — an estimated $2K sold.

MGO One Seven first reported a position in RIGL in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 131 funds tracked by Wall St. Rank hold RIGL as of Q1 2019.

MGO One Seven reported no remaining Rigel Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
MGO One Seven sold 100 Rigel Pharmaceuticals shares in Q1 2019, an estimated $2K.
MGO One Seven first reported a position in Rigel Pharmaceuticals in Q4 2018 and held it in 1 quarter.
MGO One Seven's Rigel Pharmaceuticals position peaked at $2K in Q4 2018.
131 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.